Hormone replacement therapy, contraceptives and adrenaline pens are all on the government’s list.
Category Archives: Body Optimization
Vaping-associated lung injury may be caused by toxic chemical fumes, study finds
Research into the pathology of vaping-associated lung injury is in its early stages, but a Mayo Clinic study published in The New England Journal of Medicine finds that lung injuries from vaping most likely are caused by direct toxicity or tissue damage from noxious chemical fumes.
Researchers reviewed lung biopsies from 17 patients, all of whom had vaped and were suspected to have vaping-associated lung injury. The study was the first to examine a group of biopsies from patients with lung injury due to vaping. Researchers found no evidence of tissue injury caused by accumulation of lipids — fatty substances such as mineral oils — which has been suspected as a possible cause of the lung injuries associated with vaping.
“While we can’t discount the potential role of lipids, we have not seen anything to suggest this is a problem caused by lipid accumulation in the lungs. Instead, it seems to be some kind of direct chemical injury, similar to what one might see with exposures to toxic chemical fumes, poisonous gases and toxic agents,” says Brandon Larsen, M.D., Ph.D., a surgical pathologist at Mayo Clinic Arizona, and a national expert in lung pathology.
The Centers for Disease Control and Prevention (CDC) has reported more than 800 lung injury cases that are associated with electronic cigarette use, or vaping, over the past few months. Twelve deaths have been confirmed in 10 states, and investigative findings suggest that products containing THC — the principal psychoactive compound in marijuana — or other cannabis oils, such as cannabidiol or CBD, may play a role in the outbreak.
Some states have imposed a temporary ban on the sale of e-cigarettes or flavored liquids used in them while researchers investigate health-related issues. The Food and Drug Administration is considering a ban on all nontobacco flavors of vaping liquids. The CDC recommends that e-cigarettes should not be used by children, young adults, pregnant women or adults who don’t already use tobacco products. The American Lung Association has warned that e-cigarettes are not safe and can cause irreversible lung damage and disease.
Of the 17 biopsies that were examined, two were from Mayo Clinic patients. The others were from hospitals around the country that were sent to Mayo Clinic for further investigation. All of the patients had vaped, and 71% had vaped with marijuana or cannabis oils. All showed acute lung injury, including pneumonitis, and two of the patients died.
“We were not surprised by what we found, regarding toxicity,” says Dr. Larsen, senior author of the study. “We have seen a handful of cases, scattered individual cases, over the past two years where we’ve observed the same thing, and now we are seeing a sudden spike in cases. Our study offers the first detailed review of the abnormalities that may be seen in lung biopsies to help clinicians and pathologists make a diagnosis in an appropriate clinical context.”
Vaping-associated lung injury can be difficult to diagnose, unless clinicians and pathologists are armed with information beforehand, Dr. Larsen says.
“This is a public health crisis, and a lot of people are working frantically around the clock to find out what the culprit or culprits could be — and what chemicals may be responsible,” Dr. Larsen says. “Based on what we have seen in our study, we suspect that most cases involve chemical contaminants, toxic byproducts or other noxious agents within vape liquids.”
In the meantime, the public should heed what leading medical organizations and public health agencies are saying about the dangers of vaping.
“Everyone should recognize that vaping is not without potential risks, including life-threatening risks, and I think our research supports that,” he says. “It would seem prudent based on our observations to explore ways to better regulate the industry and better educate the public, especially our youth, about the risks associated with vaping.”
Story Source:
Materials provided by Mayo Clinic. Note: Content may be edited for style and length.
Cancer data provide insights into occurrence, overdiagnosis, and treatment advances
Critical questions about progress in the fight against cancer cannot be answered simply by looking at rates of cancer incidence, a special report published in the New England Journal of Medicine finds. H. Gilbert Welch, MD, MPH, a senior investigator in the Center for Surgery and Public Health at Brigham and Women’s Hospital, and colleagues analyzed 40 years of cancer burden data and examined patterns of incidence and mortality for various cancers, finding examples for which incidence and mortality moved in concert — such as lung cancer — and examples where discordance in incidence and mortality indicate that overdiagnosis may be at play.
“Cancer incidence is not a reliable measurement of cancer burden,” said Welch. “Rising incidence may not reflect rising true cancer occurrence but instead reflect overdiagnosis; that is, the detection of small cancers not destined to cause symptoms or death. Overdiagnosis can either be the result of purposely looking harder for the disease — that is, cancer screening — or from stumbling onto small cancers while testing patients for something else. It’s an issue that’s been around for years but this paper highlights that we can’t rely on cancer incidence alone.”
Welch and colleagues examined mortality and incidence patterns from 1975 through 2015 for selected cancers in the United States. The investigators used mortality data from the National Vital Statistics System, maintained by the National Center for Health Statistics, and incidence data from the Surveillance, Epidemiology, and End Results (SEER) Program.
The team illustrated mortality and incidence trends for each cancer and characterized the resulting “signatures.” In some cases, they found a desirable signature: for Hodgkin’s lymphoma and chronic myeloid leukemia (CML), mortality rates have declined, reflecting either gradual treatment improvements (for Hodgkin’s lymphoma) or rapid treatment improvements (CML). Another important example of a desirable signature is lung cancer, where both incidence and mortality have risen and fallen together — the rise and fall of cigarette smoking is followed, three decades later, by the rise and fall of lung cancer occurrence and lung cancer death.
The team also finds good news in rates of stomach, cervical and colorectal cancer, all three of which are simply less common than they were in 1975. The authors point out some likely explanations of these favorable trends, including the decline of a powerful risk factor for stomach cancer (the bacterium Helicobacter pylori) and better screening and treatment of precancerous lesions for cervical cancer.
The authors also provide examples of undesirable signatures, likely reflecting the problem of overdiagnosis. For thyroid cancer, kidney cancer, and melanoma, rates of cancer incidence appear to be rising steeply, but rates of cancer mortality are largely unchanged.
While Welch and colleagues laud the efforts of the federal government to track data and make them publicly accessible, they call for including a critical piece of information in cancer databases in the future: mode of cancer detection. Did the patient present with symptoms? Was the patient screened for cancer? Was their cancer detected by chance?
“Many people have assumed that additional screening is the best thing for population health, but in fact it may not be. You don’t test a population to health,” said Welch.
Story Source:
Materials provided by Brigham and Women’s Hospital. Note: Content may be edited for style and length.
In women with HIV, TB preventive therapy poses greater risk in pregnancy than postpartum
Study results published today help clarify how to safely prevent tuberculosis (TB) in women living with HIV who are pregnant or have recently given birth, are taking antiretroviral therapy, and live where TB is highly prevalent.
A clinical trial funded by the National Institutes of Health has found that for these women, treatment with the antibiotic isoniazid to prevent TB was similarly safe if begun during pregnancy or 12 weeks after delivery. However, there was significantly greater risk of poor health outcomes and death for the fetuses and newborns of these women if isoniazid preventive therapy began during pregnancy than if it began 12 weeks after delivery. This finding is concerning and merits research into alternative approaches to TB preventive therapy in pregnant women, according to the study investigators. Their findings are reported in the Oct. 3 issue of The New England Journal of Medicine.
“Pregnant women are often excluded from clinical research, which leads to an information gap that can pose a danger to maternal and infant health,” said Anthony S. Fauci, M.D. “The findings reported today give women, health-care providers and policy makers high-quality data for weighing the risks and benefits of TB preventive therapy for pregnant women living with HIV who are taking antiretroviral therapy.” Dr. Fauci is Director of the National Institute of Allergy and Infectious Diseases, a component of NIH that co-funded the trial.
TB is the top infectious-disease killer worldwide and the leading cause of death for people living with HIV. Among women, TB mainly affects those of reproductive age. When active TB disease develops during pregnancy or in the weeks after birth, it is associated with poor health outcomes for both the mother and baby.
The study published today found that one or more of a set of poor health outcomes for fetuses and newborns occurred in 24% of pregnancies of women who began taking isoniazid during pregnancy and in 17% of pregnancies of women who began after delivery, a statistically significant difference. This set of poor health outcomes included stillbirth, spontaneous abortion, low birth weight, preterm delivery and congenital abnormalities. When these outcomes were evaluated individually, however, there was no statistically significant difference between the two groups. Nevertheless, the greater incidence of the set of poor pregnancy outcomes in women who began taking isoniazid during pregnancy without any reduction in the risk of TB or improvement in maternal or infant survival is troubling, the investigators conclude.
Medical experts have agreed that generally there is a net benefit to treating active TB during pregnancy and providing isoniazid to prevent active TB in people living with HIV. World Health Organization guidelines currently recommend initiating isoniazid preventive therapy in pregnant women with HIV based on data from nonpregnant adults. However, because pregnant women have previously been excluded from clinical trials of isoniazid preventive therapy, information about the safety, efficacy and appropriate timing of this approach to preventing TB in pregnant women living with HIV and taking antiretroviral therapy (ART) is lacking.
The trial reporting today, TB APPRISE (TB Ante vs. Postpartum PRevention with INH in HIV Seropositive mothers and their Exposed infants), sought to help fill this knowledge gap. The study began in August 2014 at 13 sites in Botswana, Haiti, India, South Africa, Tanzania, Thailand, Uganda and Zimbabwe. The investigators selected these countries in part because they have a high burden of TB — at least 60 of every 100,000 people have the disease.
Also known as IMPAACT P1078, the trial was conducted by the NIH-funded IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) Network and was led by Amita Gupta, M.D., M.H.S. Dr. Gupta is a professor of medicine and international health at the Johns Hopkins School of Medicine and deputy director of the Johns Hopkins University Center for Clinical Global Health Education. The IMPAACT Network is co-funded by NIAID, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Institute of Mental Health, all part of NIH.
The TB APPRISE study team enrolled 956 pregnant women ages 18 years or older who were living with HIV and were at 14 to 34 weeks gestation. All but one of the women was taking ART at enrollment. None of the women had suspected active TB, recent known TB exposure, or TB treatment for more than 30 days in the previous year.
Study participants were assigned at random to begin taking daily oral isoniazid either during pregnancy or 12 weeks after delivery. The women who began treatment during pregnancy received tablets of 300 milligrams (mg) isoniazid to take daily from enrollment until their 28th week in the study, and then received identical placebo tablets to take daily until their 40th week after delivery. The women whose treatment was deferred received placebo tablets to take daily from enrollment until 12 weeks after delivery, and then received identical tablets of 300 mg isoniazid to take daily for 28 weeks. Neither the women nor the TB APPRISE investigators knew who was in the immediate treatment group or the deferred treatment group until the end of the trial.
The participants had follow-up visits with study staff every four weeks during pregnancy and delivery. There were 926 deliveries. Then the women and their infants were followed every four weeks after delivery for 48 weeks.
Adherence to the isoniazid treatment regimen was assessed based on self-report and pill counts. By those measures, roughly 88% of study participants completed at least 90% of the treatment regimen. There was no difference in adherence between the two treatment groups.
Some 15% of the women in both treatment groups either experienced serious side-effects or stopped taking isoniazid because the side effects were too difficult to tolerate. There was no statistically significant difference in the rate of these events between the two groups.
Two women in the immediate group and four in the deferred group died, all during the postpartum period, but only two of these women — one in each group — had taken isoniazid. Three women in each group developed TB. These differences were not statistically significant.
“The TB APPRISE study team is extremely grateful to the women who participated in this clinical trial,” said Dr. Gupta. “They have helped underscore the point that data from studies in non-pregnant women cannot always be extrapolated to pregnant women, so clinical trials must include pregnant women to accurately inform global health policy.”
Home Office reverses deportation threat to Liverpool doctor
The Home Office reconsidered the case of Mu-Chun Chiang, who has lived in the UK for 13 years.
Health24.com | Red meat unhealthy? Maybe not, after all
Cutting back on red meat is standard medical advice to prevent cancer and heart disease – but a review of dozens of studies has concluded that the potential risk is low and evidence uncertain.
In new guidelines published in the Annals of Internal Medicine, a panel of researchers from seven countries suggested that “adults continue current unprocessed red meat consumption”.
The advice – which immediately drew a sharp reaction from other experts – added that adults should also “continue current processed meat consumption”.
The research, published in the journal edited by the American College of Physicians, analysed multiple studies that, taken together, showed reducing red meat consumption by three servings per week could lower cancer mortality by seven deaths per 1 000 people.
Three servings per week
Researchers said any such decline was modest and that they had found only a “low” degree of certainty about the statistic.
They added that the quality of evidence linking processed meat with cardiovascular diseases and diabetes was “very low”.
“There are very small risk reductions in cancer, heart disease and diabetes, however the evidence is uncertain,” Bradley Johnston, an epidemiology professor at Canada’s Dalhousie University and director of the NutriRECS group that put together the guidelines, told AFP.
“So there may be a reduction – or there may not be.
“People need to make their own decisions. We are giving them the best estimate of the truth.”
Steaks, sausages back on menu?
The researchers said they want to change the “old school” approach of giving general nutritional recommendations, and to bring more focus on evidence of individual benefit.
“People should look at this and hopefully make more well-informed personal choices, rather than being told what to do by authoritative organisations,” Johnston said.
But eating less red meat and processed meat has been a cornerstone of dietary guidance for decades in many countries and from leading health groups.
The World Health Organization International Agency for Research on Cancer says that processed meat is carcinogenic, while red meat is “probably carcinogenic”.
In response to the latest guidelines, the World Cancer Research Fund said it would not change its advice.
Few clear answers
“We maintain our confidence in the rigorous research conducted for 30 years,” said its director of research, Giota Mitrou.
Marji McCullough, epidemiologist at the American Cancer Society, said the researchers had taken into account people’s personal values and preferences.
“It’s kind of like saying: ‘We know helmets can save lives, but some people still prefer the feeling of the wind in their hair when they ride bikes. And let’s face it, most people won’t crash,'” she said.
“But everyone agrees you should wear a helmet.”
Kevin McConway, emeritus professor of applied statistics at Britain’s Open University, said the lack of hard scientific evidence meant there were few clear answers.
“Depressingly, all this tends to indicate that after all these years and all these millions of research participants, we still don’t know much,” he said.
Image credit: iStock
NEXT ON HEALTH24X
Beyonce’s father Mathew Knowles reveals breast cancer diagnosis
Mathew Knowles will talk about having the condition on Wednesday’s edition of Good Morning America.
Health24.com | Can older women stop getting mammograms?
Although regular screening mammograms can catch breast cancer early, new research suggests women over 75 who have chronic illnesses can probably skip this test.
The study findings indicate that women with chronic conditions, such as heart disease or diabetes, would likely die from those conditions before developing breast cancer.
“For those 75 and over with chronic illness, the benefit of continued mammography is minimal. Women 75 to 84 are 123 times more likely to die of other causes than breast cancer,” said the study’s senior author, Dejana Braithwaite.
That doesn’t mean all women over 75 should forgo mammography. “In healthy women age 75 and older, perhaps mammograms may make sense. It’s important to individualise the decision. Women should discuss with their providers the potential benefits of continuing mammography,” Braithwaite said. She’s an associate professor of epidemiology and oncology at Georgetown University’s Lombardi Comprehensive Cancer Center, in Washington, DC.
Professional guidelines vary in their recommendations for mammography in older women. The American Cancer Society advises women to stop screening when their life expectancy is less than 10 years. Meanwhile, the US Preventive Services Task Force (USPSTF) says there is not enough evidence to guide women’s decisions about mammography at age 75 and up. Many European breast cancer programmes stop recommending screening between 69 and 74 years.
One reason for these variations is there are few studies looking specifically at how mammography might benefit older women, the researchers noted.
Abnormal cells
To help fill that gap, the investigators looked at more than 222 000 women who’d had a mammogram between 1999 and 2010. The women were between the ages of 66 and 94. They were recruited from five US centres.
The researchers tracked breast cancer cases, deaths from breast cancer and deaths from other causes for 10 years. During that time, almost 7 600 of the women were diagnosed with an invasive breast cancer. More than 1 700 had abnormal cells considered very early breast cancer (DCIS).
During those 10 years, 471 women died from breast cancer. More than 42 000 died from other causes, the findings showed. Breast cancer deaths accounted for between 0.2% and 0.3% of all deaths in women between 66 and 94.
Over time, the risk of dying from breast cancer stayed steady while the risk of death from other causes rose. The investigators also found that the risk of being diagnosed with a new breast cancer after age 75 went down slightly over time.
Deana Baptiste, director of cancer screening guideline development at the American Cancer Society, said this research “reinforces the guidelines we put out in 2015 that recommended that women should continue mammography as long as their overall health is good”.
There’s no set cut-off age for stopping mammography, she added.
In line with current guidelines
Like the researchers, the cancer society also emphasises the need for individualised decisions about screening.
“A healthy woman with at least 10 years of life expectancy should be assessed by a clinician, discuss the risks and harms, and apply personal preferences about whether screening should continue,” Baptiste said.
Dr Bonnie Litvack, director of women’s imaging at Northern Westchester Hospital in Mount Kisco, New York, said this study seems in line with current guidelines.
“Women need to understand the risks and benefits of continued screening, but there’s no established age to stop. The age to stop screening should be tailored to the individual patient,” she said.
The study was published in the Journal of the National Cancer Institute.
Image credit: iStock
Health24.com | Prolapse or incontinence? You might want to avoid ‘surgical mesh’
First off, what is surgical mesh and why should you worry about it? “Mesh” is a fabric-like material used as a reinforcement for tissue or bone, and for over 50 years it’s been used in surgeries to repair hernias and prevent reoccurrence.
So far, so good. But its uses evolved to repairing tissue in the pelvic region, which is where the trouble started. Since then, many patients, the majority of them women, have been doomed to a lifetime of pain and discomfort.
“The Mesh totally ruined my life”
So says Phindile Mncube, who had surgical mesh implanted without her knowledge. “I sometimes can’t even get out of bed and have to ask my mom for help. I can’t go anywhere without drugging myself with pain tablets. The pain affects me in such a way that I can no longer work or play with my kids.”
READ MORE: Vaginal Fluid Transplants Might Be The Answer To Recurring Bacterial Vaginosis
In 2016, Phindile was experiencing excessive bleeding and severe period pains. Doctors diagnosed a hematoma and performed surgery to drain it. But after two years, her condition had become worse. “I was in a lot of pain and constantly sick, so I went to another hospital. [Later] I found out I was put in a mesh. The mesh was put in without my consent and I was kept in the dark about it,” she explains.
But removing it could be life-threatening…
Erosion of the mesh can cause damage to the surrounding organs, but removing surgical mesh is a difficult task – as Phildile found out. “I’d done research about removing the mesh, but the doctor who found it said it’s impossible. The mesh is attached to my intestines and uterus, so it’s too dangerous, life-threatening,” she explains.
READ MORE: 6 Of The Most Common Myths About Endometriosis
These dangers have resulted in countries like the US, UK, Australia and New Zealand banning or restricting the use of surgical mesh. In a review article, authored by Professor of Materials Engineering at Trinity College Dublin, David Taylor, said: “Chemical degradation of the material due to bacterial infection, and poor surgical technique, are two potential reasons for the failures, but further work is needed — especially the examination of failed mesh products — to properly determine the underlying causes of this problem.”
But while the medical field figures out whether surgical mesh does cause more harm than good, women like Phindile are left to deal with the side effects. “I take pain medication and try to avoid eating inflammatory foods. I also try not to move too much and relax my body most of the time,” she says.
So, what does this have to do with you?
If you’re ever in a position where you might need to have surgical mesh inserted to fix a prolapse or urinary incontinence, talk to your doctor about your options. And as gynaecologist and endoscopic surgeon Dr Natatalia Novikova explains, there are plenty. “Pelvic floor exercises are effective in milder forms of prolapse. We also have new tech such as vaginal laser and radiofrequency non-invasive office procedures, which are helpful for women with mild prolapse,” she says. But in cases where the prolapse is more severe, surgery would be needed.
READ MORE: Here’s How To Tell If That Pain In Your Abdomen Is Ulcerative Colitis
Stress urinary incontinence is a condition where women leak urine as they jump, sneeze, cough and run. Traditional treatment includes pelvic floor exercises and, if these don’t work, the next step is a sling procedure, where surgical mesh (much smaller than vaginal surgical mesh used for prolapse repair) is inserted through the vaginal wall underneath the urethra.
“Alternative surgery to a sling is a surgical procedure called Burch (a keyhole procedure where the neck of the bladder is suspended from nearby ligaments with sutures) or an injection of Bulkamid, where a bulking agent is injected around the urethra. It has very promising results for mild to severe stress urinary incontinence,” says Dr Novikova.
The bottom line
While surgical mesh has shown promising results when used to repair hernias, the results from its uses in gynaecological surgeries are less successful. There is no guarantee of how a patient will react to surgical mesh, but discussing your options with your doc will help find the right one for you – one that won’t negatively affect your quality of life.
This article was originally published on www.womenshealthsa.co.za
Image credit: iStock
A metronome for quantum particles
Physicists have found a way to measure the elusive quantum phase of electrons. This enables a new, better view of important phenomena used in photosensors or photovoltaics. It is like a microscope for time: Today’s methods of attosecond physic allows us to measure extremely short time intervals. With the help of short laser pulses, physical processes can be investigated on a time scale of attoseconds — that is billionths of a billionth of a second.
For example, it is possible to study how a single atom is ionized and how an electron leaves the atom. The electron does not simply behave like a point-like particle, but its quantum-physical wave properties play an important role: the electron is actually an electron wave that oscillates on an extremely short time scale — and on a tiny length scale. It is a huge challenge to measure the cycle duration of such an oscillation, but It is even much more difficult to determine its phase: What exactly is the beat the electron oscillation follows? If an electron can be ionized in two different ways, will both electron waves oscillate in perfect unison, or will there be a small time delay (i.e. a phase shift)? A team from TU Wien (Vienna) and the CREOL College at the University of Central Florida has now developed a method to measure the phase of such electron waves. This enables a new, better view of important phenomena used in photosensors or photovoltaics.
Are the electrons or out of sync?
“Any wave consists of wave crests and wave troughs — and the phase of the wave tells us at which points in space and time they are located,” says Stefan Donsa, who developed the new measuring method, working on his dissertation in the research group of Prof. Joachim Burgdörfer (Institute for Theoretical Physics, TU Wien). “If two quantum waves overlap in such a way that each wave peak of one wave meets a wave peak of the other wave, then they add up. But if you shift one of the waves a little so that the wave crest of one wave is superimposed with the wave trough of the other wave, they can also cancel out.” Therefore, phase shifts play a very important role in quantum physics.
It is similar to finding the right rhythm in music: it is not enough for two musicians to play at the same tempo. Their beats must also coincide exactly in time, without any phase shift in between. For this you need a reference clock, such as a conductor or a metronome. The newly developed quantum measurement protocol uses something similar: one atomic process serves as a reference for the other.
One or two photons
“In computer simulations, we have studied helium atoms which are ionized by laser pulses at different energies,” says Iva Brezinova. “The helium atom can absorb a photon from the laser pulse and emit an electron. This electron then has a specific phase, which is extremely difficult to measure.”
The trick of the newly developed method is to add a second quantum effect as a clock — serving as a quantum metronome, so to speak. Instead of absorbing only one photon, the atom can also absorb two photons at once, under certain conditions. This double absorption leads to the same final result — an electron flying away with very specific energy. But this time this electron has a different phase, and this difference can be measured.
Complicated measurement protocols
In attosecond physics it is not possible to simply create a movie of a quantum physical system with a camera. Instead, complicated experimental protocols have to be used. Various such protocols are currently in use, but none of them has so far allowed direct measurement of the electron phase.
The new protocol, which has now been developed by the Viennese team, should make this possible. “Our new measurement protocol allows us to translate the information about the electron phase into its spatial distribution by combining very special laser pulses,” explains Stefan Donsa. “By using the correct type of laser pulses, phase information can be directly obtained from the angular distribution of the electrons.”
The newly proposed experimental protocol has now been published in the journal Physical Review Letters. Now experiments are to test the limits of this method, in order to see which quantum mechanical information can be obtained in practice using the new protocol.
Story Source:
Materials provided by Vienna University of Technology. Note: Content may be edited for style and length.






